Medical societies accused of being beholden to the drugs industry

BMJ 1999; 319 doi: 10.1136/bmj.319.7221.1321 (Published 20 November 1999)
Cite this as: BMJ 1999;319:1321.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Scott Gottlieb
  1. New York

    Some prestigious medical organisations are coming under criticism for being too beholden to the pharmaceutical industry for their income.

    In a study published in the Western Journal of Medicine Dr Peter Glassman, of the University of California in Los Angeles, and colleagues charged that the increasing reliance of doctors' organisations on pharmaceutical advertising is placing the medical organisations in jeopardy of losing their objectivity.

    In their study the authors evaluated the primary clinical journals of several leading medical organisations, including the Journal of the American College of Cardiology, Annals of Internal Medicine, Journal of the American Medical Association, American Journal of Respiratory and Critical Care Medicine, Clinical Infectious Diseases, and the New England Journal of Medicine.

    They found that …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL